Literature DB >> 26434863

Patterns of Esophageal Cancer in the National Cancer Institute at the University of Gezira, in Gezira State, Sudan, in 1999-2012.

Nagla Gasmelseed1, Daffalla Abudris, Ahmed Elhaj, Elgaylani A Eltayeb, Ahmed Elmadani, Moawia M Elhassan, Khadiga Mohammed, Elgaili M Elgaili, Moawia Elbalal, Joachim Schuz, Maria E Leon.   

Abstract

BACKGROUND: Esophageal cancer (EC) is among the most common malignancies in Eastern Africa, but the occurrence of EC in Sudan has rarely been described in the scientific literature. This paper reports the results of a consecutive case series of all EC patients who visited one of the two public cancer treatment centers in the country in 1999-2012, providing a first description of this disease in a treatment center located in central Sudan.
MATERIALS AND METHODS: Clinical and demographic data for all EC patients who visited the Department of Oncology of the National Cancer Institute at the University of Gezira (NCI-UG) from 1999 to the end of 2012 were abstracted and tabulated by sex, tumor type and other characteristics.
RESULTS: A total of 448 EC patients visited NCI-UG in 1999-2012, and the annual number of EC cases increased steadily from 1999. Squamous cell carcinoma (SCC) was the predominant EC tumor type (90%), and adenocarcinoma (ADC) was reported in 9.4% of the EC cases. The overall male-to-female ratio for EC was 1:1.8, but the ratio was tumor type-dependent, being 1:2 for SCC and 2:1 for ADC. Only 20% of EC patients reported having ever used tobacco and/or alcohol, and the vast majority of these patients were male. At the time of EC diagnosis, 47.3% of the patients resided in Gezira State. Some EC patients from Gezira State seek out-of-state treatment in the national capital of Khartoum instead of visiting NCI-UG.
CONCLUSIONS: The annual number of EC patients visiting NCI-UG has increased in recent years, approximately half of these patients being from Gezira State. Although this consecutive series of EC patients who visited NCI-UG was complete, it did not capture all EC patients from the state. A population- based cancer registry would provide more complete data required to better understand EC patterns and risk factors.

Entities:  

Mesh:

Year:  2015        PMID: 26434863     DOI: 10.7314/apjcp.2015.16.15.6481

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

Review 1.  Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.

Authors:  V A McCormack; D Menya; M O Munishi; C Dzamalala; N Gasmelseed; M Leon Roux; M Assefa; O Osano; M Watts; A O Mwasamwaja; B T Mmbaga; G Murphy; C C Abnet; S M Dawsey; J Schüz
Journal:  Int J Cancer       Date:  2016-08-24       Impact factor: 7.396

2.  Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes.

Authors:  Akwi W Asombang; Nathaniel Chishinga; Alick Nkhoma; Jackson Chipaila; Bright Nsokolo; Martha Manda-Mapalo; Joao Filipe G Montiero; Lewis Banda; Kulwinder S Dua
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

3.  Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017.

Authors:  Abigiya Wondimagegnehu; Selamawit Hirpa; Samson Wakuma Abaya; Muluken Gizaw; Sefonias Getachew; Wondimu Ayele; Robel Yirgu; Tamiru Demeke; Berhe Dessalegn; Jilcha Diribi; Mirgissa Kaba; Mathewos Assefa; Ahmedin Jemal; Eva Johanna Kantelhardt; Adamu Addissie
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

4.  Clinico-Pathological Findings and Spatial Distributions of Esophageal Cancer in Arsi Zone, Oromia, Central Ethiopia.

Authors:  Haji Aman Deybasso; Kedir Teji Roba; Berhanu Nega; Tefera Belachew
Journal:  Cancer Manag Res       Date:  2021-03-23       Impact factor: 3.989

5.  Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends.

Authors:  Daniel R S Middleton; Liacine Bouaoun; Rachel Hanisch; Freddie Bray; Charles Dzamalala; Steady Chasimpha; Diana Menya; Charles Gombé Mbalawa; Guy N'Da; Mathewos A Woldegeorgis; Ramou Njie; Moussa Koulibaly; Nathan Buziba; Josefo Ferro; Hassan Nouhou; Femi Ogunbiyi; Henry R Wabinga; Eric Chokunonga; Margaret Z Borok; Anne R Korir; Amos O Mwasamwaja; Blandina T Mmbaga; Joachim Schüz; Valerie A McCormack
Journal:  Cancer Epidemiol       Date:  2018-02-06       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.